Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma
出版年份 2019 全文链接
标题
Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma
作者
关键词
-
出版物
LEUKEMIA
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-08-29
DOI
10.1038/s41375-019-0558-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Biochemistry and structural studies of kynurenine 3-monooxygenase reveal allosteric inhibition by Ro 61-8048
- (2018) Jingjing Gao et al. FASEB JOURNAL
- Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities
- (2018) Jae Eun Cheong et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells
- (2017) A Ray et al. LEUKEMIA
- Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
- (2017) A Ray et al. LEUKEMIA
- Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs
- (2017) Gianfranco Pittari et al. Frontiers in Immunology
- Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication
- (2016) G. An et al. BLOOD
- Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors
- (2016) Jason R. Smith et al. DRUG DISCOVERY TODAY
- Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
- (2015) G. Gorgun et al. CLINICAL CANCER RESEARCH
- Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time
- (2015) Misty R. Jenkins et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells
- (2015) A Ray et al. LEUKEMIA
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- Multiple Myeloma
- (2014) Kenneth C. Anderson HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib
- (2014) A Ray et al. LEUKEMIA
- Targeted Deletion of Kynurenine 3-Monooxygenase in Mice
- (2013) Flaviano Giorgini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Remarkable Role of Indoleamine 2,3-Dioxygenase and Tryptophan Metabolites in Infectious Diseases: Potential Role in Macrophage-Mediated Inflammatory Diseases
- (2013) Yuki Murakami et al. MEDIATORS OF INFLAMMATION
- Structural basis of kynurenine 3-monooxygenase inhibition
- (2013) Marta Amaral et al. NATURE
- Kynurenines in the mammalian brain: when physiology meets pathology
- (2012) Robert Schwarcz et al. NATURE REVIEWS NEUROSCIENCE
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
- (2011) Daniel Zwilling et al. CELL
- The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
- (2011) Susanna Campesan et al. CURRENT BIOLOGY
- Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
- (2009) Dharminder Chauhan et al. CANCER CELL
- New promises for manipulation of kynurenine pathway in cancer and neurological diseases
- (2009) Gabriele Costantino EXPERT OPINION ON THERAPEUTIC TARGETS
- Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway
- (2008) B. Le Maux Chansac et al. INTERNATIONAL IMMUNOLOGY
- Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-γ?
- (2008) Thomas J. Connor et al. NEUROSCIENCE LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now